Most of the oncology drugs that received the FDA’s accelerated approval from 2011 to 2020 had some kind of FDA postmarketing safety action, according to a research letter. Safety actions included ...

Add Yahoo as a preferred source to see more of our stories on Google. Over two million people worldwide are diagnosed with colorectal cancer every year, with up to 40 per cent of these patients facing ...

A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with breast cancer.

Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...

A large international study of more than 23,000 patients has found that common medicines used to treat high blood pressure and cholesterol, as well as heartburn, may be impacting cancer treatment ...

March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Bristol Myers Squibb's combination ...

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

For more than a century, everyday painkillers have been handed over pharmacy counters to ease headaches, joint aches and fevers. Now a wave of research is revealing that some of these familiar tablets ...